# FDA 483 - Cedars-Sinai Medical Center - August 26, 2022

Source: https://www.globalkeysolutions.net/records/483/cedars-sinai-medical-center/d2f91a68-bd7e-4cb4-8e1c-a94a02f3bbeb

> FDA 483 for Cedars-Sinai Medical Center on August 26, 2022. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cedars-Sinai Medical Center
- Inspection Date: 2022-08-26
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/cedars-sinai-medical-center/00a09c88-430a-451e-b1db-94a3054e08a4)

## Related Officers

- [Dylan R. Jock](https://www.globalkeysolutions.net/people/dylan-r-jock/a083cb5e-95d7-491d-9c6d-8c36c5963ddf)
- [Emily B. Camire](https://www.globalkeysolutions.net/people/emily-b-camire/dff5f4c6-bcbe-4ef1-ac0b-1b2701b311ef)

Company: https://www.globalkeysolutions.net/companies/cedars-sinai-medical-center/0c040871-8a84-423c-ae2b-2a7748ab8111

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b